Tel +49 (0)30 560 42240, Mon - Fri, 9am - 1pm
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
Amazon Pay
CSRF token
Cookie preferences
Currency change
Customer-specific caching
Individual prices
PayPal payments
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Statistics & Tracking
Affiliate program
Google Analytics
Google Tag Manager
Track device being used
releva.nz Retargeting
Close filters
Filter by:
Date
Authors

Research and studies

Filter

TA-65® improves Cardiovascular Markers in Patients with Metabolic Syndrome.

From: TA65 Administrator 01/12/2018 00:00
A new study published by the University of Connecticut in the latest issue of Current Pharmaceutical Design shows that daily use of the telomerase activator TA-65® provided protective effects against metabolic abnormalities associated with Metabolic Syndrome.
Read more
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent.
Decline Accept all Configure